Regulation of inflammatory responses by oxidized phospholipids structure-function relationships

被引:28
作者
Furnkranz, A [1 ]
Leitinger, N [1 ]
机构
[1] Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria
关键词
oxidized phospholipids; inflammation; molecular structure; innate immunity;
D O I
10.2174/1381612043452929
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increasing evidence points to the role of oxidized phospholipids as modulators of inflammatory processes. These modified phospholipids are derived from lipoproteins or cellular membranes and accumulate at sites of inflammation such as atherosclerotic lesions. It has been shown that oxidized phospholipids influence a variety of cellular functions such as chemokine production and expression of adhesion molecules. Furthermore, recent reports indicate that oxidized phospholipids act as ligands for pattern-recognition receptors which detect conserved pathogen-associated molecular patterns during innate immune defense. Thus, the diversity of individual phospholipid oxidation products reflects the many aspects of the inflammatory process they influence. In this review, we focus on structural features used to classify different oxidized phospholipids and how they relate to specific biological responses. As the chemical identification of oxidized phospholipid products proceeds, distinctive structural motifs emerge that can help us to understand the mechanism of action of these unique compounds and how to intervene for therapeutic purposes.
引用
收藏
页码:915 / 921
页数:7
相关论文
共 60 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Pharmacology of phosphoinositides, regulators of multiple cellular functions [J].
Balla, T .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (06) :475-507
[3]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[4]   Evidence for a role of phospholipid oxidation products in atherogenesis [J].
Berliner, JA ;
Subbanagounder, G ;
Leitinger, N ;
Watson, AD ;
Vora, D .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (3-4) :142-147
[5]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[6]   Innate and acquired immunity in atherogenesis [J].
Binder, CJ ;
Chang, MK ;
Shaw, PX ;
Miller, YI ;
Hartvigsen, K ;
Dewan, A ;
Witztum, JL .
NATURE MEDICINE, 2002, 8 (11) :1218-1226
[7]  
BINDER CJ, 2003, NAT MED
[8]   Protective role of phospholipid oxidation products in endotoxin-induced tissue damage [J].
Bochkov, VN ;
Kadl, A ;
Huber, J ;
Gruber, F ;
Binder, BR ;
Leitinger, N .
NATURE, 2002, 419 (6902) :77-81
[9]   Oxidized phlospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT [J].
Bochkov, VN ;
Mechtcheriakova, D ;
Lucerna, M ;
Huber, J ;
Malli, R ;
Graier, WF ;
Hofer, E ;
Binder, BR ;
Leitinger, N .
BLOOD, 2002, 99 (01) :199-206
[10]   A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection [J].
Boes, M ;
Prodeus, AP ;
Schmidt, T ;
Carroll, MC ;
Chen, JZ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2381-2386